Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

July 15, 1988; Volume 141,Issue 2
  • You have accessRestricted access
    Differentiation potential of 14-day fetal mouse thymocytes in organ culture. Analysis of CD4/CD8-defined single-positive and double-negative cells.
    R Ceredig
    J Immunol July 15, 1988, 141 (2) 355-362;
  • You have accessRestricted access
    Antigen form influences induction and frequency of influenza-specific class I and class II MHC-restricted cytolytic T lymphocytes.
    L A Morrison, V L Braciale and T J Braciale
    J Immunol July 15, 1988, 141 (2) 363-368;
  • You have accessRestricted access
    Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation.
    W M Yokoyama, F Koning, P J Kehn, G M Pereira, G Stingl, J E Coligan and E M Shevach
    J Immunol July 15, 1988, 141 (2) 369-376;
  • You have accessRestricted access
    The activation of pigeon cytochrome c-specific T cell hybridomas by antigenic peptides is influenced by non-native sequences at the amino terminus of the determinant.
    H Bhayani, F R Carbone and Y Paterson
    J Immunol July 15, 1988, 141 (2) 377-382;
  • You have accessRestricted access
    Isotype, VH genes, and antigen-binding analysis of hybridomas from newborn normal BALB/c mice.
    D Glotz, M Sollazzo, S Riley and M Zanetti
    J Immunol July 15, 1988, 141 (2) 383-390;
  • You have accessRestricted access
    Generation of helper cell-independent cytotoxic T lymphocytes is dependent upon L3T4+ helper T cells.
    D C Roopenian and P S Anderson
    J Immunol July 15, 1988, 141 (2) 391-397;
  • You have accessRestricted access
    A regulatory role for the CD4 and CD8 molecules in T cell activation.
    H Schrezenmeier and B Fleischer
    J Immunol July 15, 1988, 141 (2) 398-403;
  • You have accessRestricted access
    T cell stimulation via CD2 molecules is regularly accompanied by an increase in cytoplasmic pH. Different effects of lectins and CD3 antibodies.
    G F Fischer, W Holter, O Majdic, E J Cragoe Jr and W Knapp
    J Immunol July 15, 1988, 141 (2) 404-409;
  • You have accessRestricted access
    Suppression of B cell function by methotrexate and trimetrexate. Evidence for inhibition of purine biosynthesis as a major mechanism of action.
    G J Rosenthal, G W Weigand, D R Germolec, J A Blank and M I Luster
    J Immunol July 15, 1988, 141 (2) 410-416;
  • You have accessRestricted access
    Differential recognition by human cytotoxic T cell clones of human M1 fibroblasts transfected with an HLA-B7 gene (JY150) suggests the existence of two different HLA-B7 alleles in the cell line JY (HLA-A2,2;B7,7;Cw-,-;DR4,w6).
    G A van Seventer, H Spits, H Yssel, C J Melief and P Ivanyi
    J Immunol July 15, 1988, 141 (2) 417-422;
  • You have accessRestricted access
    Allogeneic T cell activation triggering by MHC class I antigens.
    S Chouaib, A Bensussan, A M Termijtelen, M Andreeff, C Marchiol-Fournigault, D Fradelizi and B Dupont
    J Immunol July 15, 1988, 141 (2) 423-429;
  • You have accessRestricted access
    Defective thymic education of L3T4+ T helper cell function in graft-vs-host mice.
    M Fukuzawa, C S Via and G M Shearer
    J Immunol July 15, 1988, 141 (2) 430-439;
  • You have accessRestricted access
    Possible role of neuraminidase in activated T cells in the recognition of allogeneic Ia.
    S Taira and H Nariuchi
    J Immunol July 15, 1988, 141 (2) 440-446;
  • You have accessRestricted access
    Structural features of an antigen required for cellular interactions and for T cell activation in a MHC-restricted response.
    B C Langton, C E Mackewicz, A M Wan, M L Andria and E Benjamini
    J Immunol July 15, 1988, 141 (2) 447-456;
  • You have accessRestricted access
    Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes.
    R H Carter, M O Spycher, Y C Ng, R Hoffman and D T Fearon
    J Immunol July 15, 1988, 141 (2) 457-463;
  • You have accessRestricted access
    In vivo immunomodulation by monoclonal anti-CD4 antibody. II. Effect on T cell response to myelin basic protein and experimental allergic encephalomyelitis.
    S Sriram, L Carroll, S Fortin, S Cooper and G Ranges
    J Immunol July 15, 1988, 141 (2) 464-468;
  • You have accessRestricted access
    Epitope mapping with a recombinant human 68-kDa (U1) ribonucleoprotein antigen reveals heterogeneous autoantibody profiles in human autoimmune sera.
    H H Guldner, H J Netter, C Szostecki, H J Lakomek and H Will
    J Immunol July 15, 1988, 141 (2) 469-475;
  • You have accessRestricted access
    Direct identification of the murine IL-2 receptor p55-p75 heterodimer in the absence of IL-2.
    H Saragovi and T R Malek
    J Immunol July 15, 1988, 141 (2) 476-482;
  • You have accessRestricted access
    Development and characterization of monoclonal antibodies to murine macrophage colony-stimulating factor.
    B L Lokeshwar and H S Lin
    J Immunol July 15, 1988, 141 (2) 483-488;
  • You have accessRestricted access
    IL-4 induces co-expression of intrinsic membrane IgG1 and IgE by murine B cells stimulated with lipopolysaccharide.
    C M Snapper, F D Finkelman, D Stefany, D H Conrad and W E Paul
    J Immunol July 15, 1988, 141 (2) 489-498;
  • You have accessRestricted access
    The involvement of human tumor necrosis factors-alpha and -beta in the mixed lymphocyte reaction.
    M R Shalaby, T Espevik, G C Rice, A J Ammann, I S Figari, G E Ranges and M A Palladino Jr
    J Immunol July 15, 1988, 141 (2) 499-503;
  • You have accessRestricted access
    IL-4/B cell stimulatory factor 1 stimulates T cell growth by an IL-2-independent mechanism.
    M Brown, J Hu-Li and W E Paul
    J Immunol July 15, 1988, 141 (2) 504-511;
  • You have accessRestricted access
    Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both.
    Y Ichinose, O Bakouche, J Y Tsao and I J Fidler
    J Immunol July 15, 1988, 141 (2) 512-518;
  • You have accessRestricted access
    Amplification of IL-2-driven T cell proliferation by recombinant human IL-3 and granulocyte-macrophage colony-stimulating factor.
    D Santoli, S C Clark, B L Kreider, P A Maslin and G Rovera
    J Immunol July 15, 1988, 141 (2) 519-526;
  • You have accessRestricted access
    Synergistic and overlapping activities of tumor necrosis factor-alpha and IL-1.
    K Last-Barney, C A Homon, R B Faanes and V J Merluzzi
    J Immunol July 15, 1988, 141 (2) 527-530;
  • You have accessRestricted access
    IL-1 inhibits B cell differentiation in long term bone marrow cultures.
    K Dorshkind
    J Immunol July 15, 1988, 141 (2) 531-538;
  • You have accessRestricted access
    Characterization of the soluble murine IL-2R and estimation of its affinity for IL-2.
    D Baran, M Korner and J Theze
    J Immunol July 15, 1988, 141 (2) 539-546;
  • You have accessRestricted access
    The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage.
    A Haziot, S Chen, E Ferrero, M G Low, R Silber and S M Goyert
    J Immunol July 15, 1988, 141 (2) 547-552;
  • You have accessRestricted access
    The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.
    R Burger, G Zilow, A Bader, A Friedlein and W Naser
    J Immunol July 15, 1988, 141 (2) 553-558;
  • You have accessRestricted access
    Synthesis and regulation of complement protein factor H in human skin fibroblasts.
    Y Katz and R C Strunk
    J Immunol July 15, 1988, 141 (2) 559-563;
  • You have accessRestricted access
    Heterogeneous nature of the acute phase response. Differential regulation of human serum amyloid A, C-reactive protein, and other acute phase proteins by cytokines in Hep 3B cells.
    M K Ganapathi, D Schultz, A Mackiewicz, D Samols, S I Hu, A Brabenec, S S Macintyre and I Kushner
    J Immunol July 15, 1988, 141 (2) 564-569;
  • You have accessRestricted access
    Modulation of stimulus-dependent human platelet activation by C-reactive protein modified with active oxygen species.
    K Miyazawa, S Kiyono and K Inoue
    J Immunol July 15, 1988, 141 (2) 570-574;
  • You have accessRestricted access
    Induction of monocyte migration by recombinant macrophage colony-stimulating factor.
    J M Wang, J D Griffin, A Rambaldi, Z G Chen and A Mantovani
    J Immunol July 15, 1988, 141 (2) 575-579;
  • You have accessRestricted access
    Stimulation of human neutrophil adhesive properties by adenine nucleotides.
    D R Freyer, L A Boxer, R A Axtell and R F Todd 3rd
    J Immunol July 15, 1988, 141 (2) 580-586;
  • You have accessRestricted access
    Tumor necrosis factor-induced activation of peritoneal macrophages is regulated by prostaglandin E2 and cAMP.
    V Lehmmann, B Benninghoff and W Dröge
    J Immunol July 15, 1988, 141 (2) 587-591;
  • You have accessRestricted access
    C1q enhances the phagocytosis of Cryptococcus neoformans blastospores by human monocytes.
    D A Bobak, R G Washburn and M M Frank
    J Immunol July 15, 1988, 141 (2) 592-597;
  • You have accessRestricted access
    Characterization of the pattern of inflammatory cell influx and cytokine production during the murine host response to Listeria monocytogenes.
    S S Kratz and R J Kurlander
    J Immunol July 15, 1988, 141 (2) 598-606;
  • You have accessRestricted access
    Exact definition of species-specific and cross-reactive epitopes of the 65-kilodalton protein of Mycobacterium leprae using synthetic peptides.
    D C Anderson, M E Barry and T M Buchanan
    J Immunol July 15, 1988, 141 (2) 607-613;
  • You have accessRestricted access
    Human IFN-gamma production is inhibited by a synthetic peptide homologous to retroviral envelope protein.
    M Ogasawara, G J Cianciolo, R Snyderman, M Mitani, R A Good and N K Day
    J Immunol July 15, 1988, 141 (2) 614-619;
  • You have accessRestricted access
    Independent regulation of B cell responses to surface and subsurface epitopes of African trypanosome variable surface glycoproteins.
    D M Reinitz and J M Mansfield
    J Immunol July 15, 1988, 141 (2) 620-626;
  • You have accessRestricted access
    Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection.
    C E Davis, M Belosevic, M S Meltzer and C A Nacy
    J Immunol July 15, 1988, 141 (2) 627-635;
  • You have accessRestricted access
    Antigenic variation in Giardia lamblia.
    T E Nash, A Aggarwal, R D Adam, J T Conrad and J W Merritt Jr
    J Immunol July 15, 1988, 141 (2) 636-641;
  • You have accessRestricted access
    Molecular cloning of bovine class I MHC cDNA.
    P D Ennis, A P Jackson and P Parham
    J Immunol July 15, 1988, 141 (2) 642-651;
  • You have accessRestricted access
    The Ig kappa L chain allelic groups among the Ig kappa haplotypes and Ig kappa crossover populations suggest a gene order.
    L A D'Hoostelaere, K Huppi, B Mock, C Mallett and M Potter
    J Immunol July 15, 1988, 141 (2) 652-661;
  • You have accessRestricted access
    Two regions within the human IL-2 gene promoter are important for inducible IL-2 expression.
    T M Williams, L Eisenberg, J E Burlein, C A Norris, S Pancer, D Yao, S Burger, M Kamoun and J A Kant
    J Immunol July 15, 1988, 141 (2) 662-666;
  • You have accessRestricted access
    Slot-machine mutagenesis of a polymorphic residue on the A kappa alpha-chain.
    D Landais, S Marchetto, C Waltzinger, M Pierres, C Benoist and D Mathis
    J Immunol July 15, 1988, 141 (2) 667-671;
  • You have accessRestricted access
    Biochemical and structural properties of a Hodgkin's disease-related membrane protein.
    J F Nawrocki, E S Kirsten and R I Fisher
    J Immunol July 15, 1988, 141 (2) 672-680;
  • You have accessRestricted access
    A chronic inflammatory response. Its role in supporting the development of c-myb and c-myc related promonocytic and monocytic tumors in BALB/c mice.
    L Wolff, J F Mushinski, G L Shen-Ong and H C Morse 3rd
    J Immunol July 15, 1988, 141 (2) 681-689;
  • You have accessRestricted access
    Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    A Kasid, G I Bell and E P Director
    J Immunol July 15, 1988, 141 (2) 690-698;
  • You have accessRestricted access
    Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells.
    Y Tsuchiya, M Igarashi, R Suzuki and K Kumagai
    J Immunol July 15, 1988, 141 (2) 699-708;

ERRATA

  • You have accessRestricted access
    Mechanism of defective natural killer cell activity in patients with AIDS is associated with defective distribution of tubulin
    MC Sirianni, S Soddus, W Malorni, G Arancia and F Aiuti
    J Immunol July 15, 1988, 141 (2) 709;
  • You have accessRestricted access
    Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor
    LA Falk, LN Wahl and SN Vogel
    J Immunol July 15, 1988, 141 (2) 709-710;
  • You have accessRestricted access
    Inhibition of allergic reactions with monoclonal antibody to the high affinity IgE receptor
    S Kitani, D Kraft, C Fischler, SE Mergenhagen and RP Siraganian
    J Immunol July 15, 1988, 141 (2) 709;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 141, Issue 2
15 Jul 1988
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • ERRATA
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606